1 Key Reason the Rite Aid Rally Should Continue

Shares of Rite Aid Corporation continue to march higher amid optimism about the company's future. But how much higher will the stock climb in the year ahead?

Mar 6, 2014 at 9:46PM

Rite Aid Corporation (NYSE:RAD) has been on a tear lately, with the stock climbing more than 33% year to-date. Shares of Rite Aid were swapping hands near the stock's 52-week high on Wednesday, with shares priced at $6.74 apiece in mid-day trading. While the stock took back some of those gains today to trade around $6.61, that's still a refreshing change of pace from where Rite Aid traded last April at around $1.70 per share.

Nevertheless, the question on many investors' minds now is whether shares of Rite Aid have more upside from here. Let's take a closer look at what has been driving the stock higher in the past year, and what investors can expect from Rite Aid in 2014.

Choosing the rite path
Rite Aid's decision to renew its longtime partnership with drug distributor McKesson (NYSE:MCK) is one of the more recent catalysts fueling the stock's price gains. Earlier this month, Rite Aid said it would extend its partnership with McKesson through 2019. McKesson will provide the sourcing and distribution of brand and generic drugs to Rite Aid stores during this five-year period.

Rite Aid Corporation

Rite Aid is confident that the arrangement will create supply-chain efficiencies, as well as help the pharmacy retailer provide better service to its customers. Investors seem to agree with this verdict. The stock jumped more than 5% on this news last month. Fellow Fool Daniel Jones is confident that strategic partnerships such as this are the key to Rite Aid's future success.

The drugstore chain has done a phenomenal job of turning its fortunes around during the past year. In fact, fiscal 2013 marked one of the best years in Rite Aid's 50-year history, as the company was able to return to profitability. To get there, Rite Aid's management aggressively closed underperforming stores, and focused on transforming the company into a wellness destination. Rite Aid operated 4,587 locations as of March, down from 4,623 stores a year ago.

With the chain's recovery on track, let's look at one key reason its stock should continue to move higher in the quarters to come.

Taking care of customers
One catalyst going forward is the company's push to offer more pharmacy services outside of prescription refills. Rite Aid was able to grow its immunizations program as much as 60% in fiscal 2013, as the company administered nearly 2.4 million flu shots. This is important because immunizations like flu shots often carry profit margins of up to 50%, according to the Wall Street Journal. On top of this, administering flu shots gives Rite Aid the opportunity to sell customers on its other health-care services, such as diabetes screenings. Additionally, Rite Aid now offers Medication Therapy Management services, which it hopes will help attract more customers that are 65-years and older who suffer from multiple chronic conditions such as heart disease, arthritis, and diabetes.

More than 800 Rite Aid stores have now been remodeled into Rite Aid Wellness centers. This strategy appears to be paying off. The retailer announced today that pharmacy same-store sales increased 3.1% last month, while total drugstore sales in February spiked 2.4%, to $2.5 billion. Looking to the year ahead, the company plans to continue reinvesting in its store base by converting another 400 locations to the Wellness format in 2014.

Ultimately, by reformatting its store layouts around health and wellness, Rite Aid is transforming people's perception of its brand. If these turnaround efforts are able to drive more traffic to its stores, the rally in Rite Aid's stock could also continue.

How you can profit from this information
Want to profit on business analysis like this? The key for your future is to turn business insights into portfolio gold through smart and steady investing... starting right now. Those who wait on the sidelines are missing out on huge gains and putting their financial futures in jeopardy. The Motley Fool is offering a new special report, an essential guide to investing, which includes access to top stocks to buy now. Click here to get your copy today -- it's absolutely free.

Tamara Rutter has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information